Related Experiment Video
Updated: Aug 25, 2025
11:32
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
1.1K
Cellular and Molecular Targets in Acute Ischemic Stroke.
Peter Kraft1,2, Michael K Schuhmann2
1Department of Neurology, Klinikum Main-Spessart Lohr, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany.
International Journal of Molecular Sciences
|October 14, 2022
Summary
Ischemic stroke remains a major global health challenge. New therapeutic strategies are crucial to improve patient outcomes and reduce long-term disability.
Area of Science:
- Neurology
- Cardiovascular Research
- Public Health
Background:
- Ischemic stroke (IS) continues to be a primary cause of mortality and long-term disability globally.
- Current treatment options for IS have limitations in efficacy and accessibility.
- There is an urgent need for novel therapeutic approaches to mitigate IS-related damage.
Discussion:
- The pathophysiology of IS involves complex molecular and cellular events.
- Understanding these mechanisms is key to developing targeted interventions.
- Research is exploring various pathways, including neuroprotection and reperfusion injury.
Key Insights:
- Emerging research focuses on identifying novel biomarkers for early diagnosis and prognosis of IS.
- Investigating the role of specific genetic and environmental factors in IS susceptibility.
- Evaluating the potential of innovative drug targets and treatment modalities.
Outlook:
- Future research aims to translate preclinical findings into effective clinical treatments for IS.
- Developing personalized medicine approaches for IS based on individual patient profiles.
- Improving global strategies for IS prevention, treatment, and rehabilitation.
